PCG Digital: FDA Awards $2.6 Million Grant for Expanded Study of Soligenix's Hybryte for CTCL
New York, New York--(Newsfile Corp. - September 12, 2022) - PCG Digital -- Late-stage biopharmaceutical company Soligenix, Inc. (NASDAQ: SNGX) has announced the award of a $2.6 million grant from the